Orazi A - Search Results

1

Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.

Boiocchi L, Espinal-Witter R, Geyer JT, Steinhilber J, Bonzheim I, Knowles DM, Fend F, Orazi A. Boiocchi L, et al. Among authors: orazi a. Mod Pathol. 2013 Feb;26(2):204-12. doi: 10.1038/modpathol.2012.165. Epub 2012 Sep 28. Mod Pathol. 2013. PMID: 23018876 Free article.

2

Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.

Orazi A, Cattoretti G, Heerema NA, Sozzi G, John K, Neiman RS. Orazi A, et al. Mod Pathol. 1993 Sep;6(5):521-5. Mod Pathol. 1993. PMID: 8248107

3

p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.

Orazi A, Kahsai M, John K, Neiman RS. Orazi A, et al. Mod Pathol. 1996 Jan;9(1):48-52. Mod Pathol. 1996. PMID: 8821956

4

Flow cytometric analysis of normal and reactive spleen.

Colovai AI, Giatzikis C, Ho EK, Farooqi M, Suciu-Foca N, Cattoretti G, Orazi A. Colovai AI, et al. Among authors: orazi a. Mod Pathol. 2004 Aug;17(8):918-27. doi: 10.1038/modpathol.3800141. Mod Pathol. 2004. PMID: 15263909 Free article.

5

Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining.

Ponzoni M, Savage DG, Ferreri AJ, Pruneri G, Viale G, Servida P, Bertolini F, Orazi A. Ponzoni M, et al. Among authors: orazi a. Mod Pathol. 2004 Dec;17(12):1513-20. doi: 10.1038/modpathol.3800224. Mod Pathol. 2004. PMID: 15272276 Free article.

6

Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia.

Orazi A, O'Malley DP, Jiang J, Vance GH, Thomas J, Czader M, Fang W, An C, Banks PM. Orazi A, et al. Mod Pathol. 2005 May;18(5):603-14. doi: 10.1038/modpathol.3800348. Mod Pathol. 2005. PMID: 15578075 Free article.

7

Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia.

O'Malley DP, Orazi A, Wang M, Cheng L. O'Malley DP, et al. Among authors: orazi a. Mod Pathol. 2005 Dec;18(12):1562-8. doi: 10.1038/modpathol.3800481. Mod Pathol. 2005. PMID: 16118625 Free article.

8

Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders.

O'Malley DP, Kim YS, Perkins SL, Baldridge L, Juliar BE, Orazi A. O'Malley DP, et al. Among authors: orazi a. Mod Pathol. 2005 Dec;18(12):1550-61. doi: 10.1038/modpathol.3800480. Mod Pathol. 2005. PMID: 16118626 Free article.

9

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.

Orazi A, Chiu R, O'Malley DP, Czader M, Allen SL, An C, Vance GH. Orazi A, et al. Mod Pathol. 2006 Dec;19(12):1536-45. doi: 10.1038/modpathol.3800707. Epub 2006 Oct 13. Mod Pathol. 2006. PMID: 17041567 Free article.

10

Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.

Fend F, Horn T, Koch I, Vela T, Orazi A. Fend F, et al. Among authors: orazi a. Leuk Res. 2008 Dec;32(12):1931-5. doi: 10.1016/j.leukres.2008.04.024. Epub 2008 Jun 13. Leuk Res. 2008. PMID: 18555525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters